Turning point brands Sr VP Cushman sells $1.13M in stock

Turning Point Brands, Inc. (NYSE:TPB) Senior Vice President and General Counsel Brittani Cushman recently sold a significant portion of her holdings in the company, according to a filing with the Securities and Exchange Commission. Cushman sold a total of 15,000 shares over two days, June 9 and June 10, at prices ranging from $74.36 to $75.89 per share, totaling approximately $1.13 million. The sale comes as the company, currently valued at $1.34 billion, has delivered impressive returns of nearly 140% over the past year.

In a related transaction, Cushman exercised options to acquire 15,000 shares at a price of $13 per share, amounting to a total purchase value of $195,000. Following these transactions, her direct ownership stands at 34,687 shares of common stock. According to InvestingPro data, the company maintains strong fundamentals with an impressive 55.4% gross profit margin.

The transactions were part of Cushman’s ongoing management of her equity holdings in Turning Point Brands, which is known for its portfolio of tobacco products. Based on InvestingPro’s Fair Value analysis, the stock appears to be trading near its fair value. Investors can access detailed valuation metrics and 12 additional ProTips through InvestingPro’s comprehensive research platform.

In other recent news, Turning Point Brands reported strong financial results for the first quarter of 2025, surpassing both earnings and revenue forecasts. The company achieved an earnings per share of $0.91, exceeding the expected $0.71, while revenue reached $106.4 million, beating the forecast of $92.53 million. This performance reflects a 28% year-over-year increase in revenue, driven by significant growth in the Modern Oral segment. Additionally, the company’s adjusted EBITDA rose by 12% compared to the previous year, reaching $27.7 million. In other developments, Turning Point Brands held its Annual Meeting of Stockholders, where all nominated directors were elected, and key proposals, such as limiting officer liability and ratifying KPMG LLP as the independent accountant, were approved. Moreover, the company projects an adjusted EBITDA of $108-113 million for the remainder of 2025, with anticipated tariff impacts and a budget for capital expenditures. Analyst firms like Craig Hallum Capital Group and Alliance Group Global Partners (NYSE:GLP) have shown interest in the company’s distribution expansion and marketing strategies, especially in the Modern Oral category.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.